BRIDGING BOUNDARIES: INNOVATING, CONNECTING & RESHAPING DRUG REPURPOSING
Over 250 experts from around the globe gathered in Barcelona for the inaugural International Drug Repurposing Conference (#iDR24) on 6-7 March 2024. Among them were prominent voices from the research and patient communities, regulatory and HTAs bodies, health authorities, and pharmaceutical and generics industries. Together, the attendees explored innovative approaches, discussed the many challenges of drug repurposing, busted myths, shared best practices, and further worked towards a healthier future for patients and society.
Photo gallery
iDR24 Articles
Insights from iDR24 Speakers
Listen to some of our key speakers of the 2024 event and their insights on the importance of the iDR Conference Series.
Co-organisers
REMEDi4ALL
REMEDi4ALL is an EU-funded research initiative that is driving forward the repurposing of medicines in Europe.
Beacon for rare diseases
Beacon is a UK-based charity that is building a united rare disease community with patient groups at its heart.
MeRIT
The Medicines Repurposing International Network (MERIT) supports collaboration and communication between publicly funded repurposing initiatives.
Sponsors
LIFEARC
LifeArc is a self-financing medical research charity. Our ambition is to transform the way diseases are identified and treated.